Investigational and repurposed drugs for COVID-19 treatment
At the beginning of June, 42,000 research articles were published on COVID-19 and 3,100 clinical trials registered. A vast amount of information is now available on COVID-19, an encouraging development that tells us the research community is working hard to get us closer to a resolution of this crisis. But whether you are a clinical researcher directly involved in COVID-19 studies or someone doing basic/interdisciplinary research relevant to COVID-19, you are likely to find it difficult to get a clear overview of all the new information, especially on drugs that can potentially treat COVID-19.
We bring you an infographic that does exactly that. We chose five of the drugs currently being tested in clinical trials and listed the most important and relevant facts about them.
Feel free to download this infographic and share it with your peers.
The information in this piece is based on powered by R Concept (a initiative) for those involved in COVID-19–related research. for regular literature updates!
You're looking to give wings to your academic career and publication journey. We like that!
Why don't we give you complete access! Create a free account and get unlimited access to all resources & a vibrant researcher community.